Abstract: Polymers including bifunctional mono- or poly-cyclic heterocyclic or heteroaromatic repeating units having disinfecting activity, compositions thereof, and methods for disinfecting surfaces utilizing the compositions. The method for disinfecting includes brushing, spraying, wiping, casting, dipping, or vapor coating, to the surface a disinfecting material to thereby render the surface antiseptic. The surface being disinfected by this method may be smooth, rough, tough, or soft, and may be selected from a cardboard, cloth, stainless steel or metallic surface, plastic, glass, wood, paper, surgical glove, or skin.

Abstract: The present invention provides, in certain embodiments, compositions comprising a uniform population of free, single crystals of a hydrophobic compound. Methods of administering, and processes for preparing, compositions comprising a uniform population of free, single crystals of a hydrophobic compound are also provided.

Abstract: Polymers containing nitrogen-halogen covalent bonds, i.e., N-halamine polymers, are provided for use in water treatment by reducing or removing microbes and toxic chemicals. Polymers containing one or more amide groups, guanidino groups, or groups derived from urethane or urea, are directly halogenated. The hydrolysis of N-halamine bonds is closely monitored by the presence of different electron-donating or electron-withdrawing groups adjacent to the nitrogen(s) of the N-halamine groups, and the resultant polymer can be facilely reloaded with halogen. Released halogen is in the form of an oxidative halogen or a hypohalous acid, in an effective amount and in an extended period of time, to significantly reduce the amount of a wide range of microbes including Escherichia coli and bacteriophage MS2 in contaminated water. Sponges, beads, resins, gel, and membranes made from these polymers are used in water treatment.

Abstract: The present invention provides, in certain embodiments, compositions comprising a uniform population of free, single crystals of a hydrophobic compound. Methods of administering, and processes for preparing, compositions comprising a uniform population of free, single crystals of a hydrophobic compound are also provided.

Abstract: Described herein are methods of preventing or reducing fibrosis comprising administering CSF1R inhibitors, coating formulations comprising CSF1R inhibitors, coatings comprising CSF1R inhibitors for implantable medical devices, CSF1R inhibitor coated implantable medical devices, as well as corresponding embodiments comprising additional agents.

Abstract: Polymers containing nitrogen-halogen covalent bonds, i.e., N-halamine polymers, are provided for use in water treatment by reducing or removing microbes and toxic chemicals. Polymers containing one or more amide groups, guanidino groups, or groups derived from urethane or urea, are directly halogenated. The hydrolysis of N-halamine bonds is closely monitored by the presence of different electron-donating or electron-withdrawing groups adjacent to the nitrogen(s) of the N-halamine groups, and the resultant polymer can be facilely reloaded with halogen. Released halogen is in the form of an oxidative halogen or a hypohalous acid, in an effective amount and in an extended period of time, to significantly reduce the amount of a wide range of microbes including Escherichia coli and bacteriophage MS2 in contaminated water. Sponges, beads, resins, gel, and membranes made from these polymers are used in water treatment.

Abstract: Articles-of-manufacturing comprising an object having a surface and at least a first layer of a first therapeutically active agent being deposited onto at least a continuous portion of the surface, wherein at least 50 weight percents of the first layer is the first therapeutically active agent in a crystalline form are disclosed. Methods utilizing such articles-of-manufacturing for treating medical conditions are also disclosed. Processes of preparing the articles-of-manufacturing by contacting a surface of the object with a solution containing the therapeutically active agent, without cooling the surface to a temperature below a temperature of the solution, are also disclosed.

Abstract: Articles-of-manufacturing comprising an object having a surface and at least a first layer of a first therapeutically active agent being deposited onto at least a continuous portion of the surface, wherein at least 50 weight percents of the first layer is the first therapeutically active agent in a crystalline form are disclosed. Methods utilizing such articles-of-manufacturing for treating medical conditions are also disclosed. Processes of preparing the articles-of-manufacturing by contacting a surface of the object with a solution containing the therapeutically active agent, without cooling the surface to a temperature below a temperature of the solution, are also disclosed.